Brinzolamide-brimonidine fixed combination to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy

J Cataract Refract Surg. 2018 Apr;44(4):514-515. doi: 10.1016/j.jcrs.2018.03.006. Epub 2018 Apr 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antihypertensive Agents / pharmacology
  • Brimonidine Tartrate / pharmacology*
  • Carbonic Anhydrase Inhibitors / pharmacology
  • Drug Combinations
  • Female
  • Follow-Up Studies
  • Humans
  • Intraocular Pressure / drug effects*
  • Laser Therapy / adverse effects*
  • Male
  • Middle Aged
  • Ocular Hypertension / physiopathology
  • Ocular Hypertension / prevention & control*
  • Posterior Capsulotomy / adverse effects*
  • Posterior Capsulotomy / methods
  • Postoperative Complications / physiopathology
  • Postoperative Complications / prevention & control*
  • Sulfonamides / pharmacology*
  • Thiazines / pharmacology*

Substances

  • Antihypertensive Agents
  • Carbonic Anhydrase Inhibitors
  • Drug Combinations
  • Sulfonamides
  • Thiazines
  • Brimonidine Tartrate
  • brinzolamide